Your Full-service contract research organization (CRO)

LINK Medical is a full-service Nordic CRO providing product development services for the pharmaceutical and medical device industries across Northern Europe. Our Scandinavian roots and culture provide a high-quality service delivery based on respect, work integrity and a strong focus on solutions. We are a pragmatic problem-solver, empowering our experienced specialists with modern technology that will change your expectations of a CRO partner. Our promise is to improve and accelerate your product development through transformative methods, active communication and optimal solutions.

A strategic partnership

We offer a strategic partnership, providing you with highly competent teams and evidence-based documentation that drive superior clinical outcomes. Reaching from early phase development to post-marketing, we provide expert guidance through every stage of product development – all from ONE source. You can rely on smooth service delivery through the LINK Advantage, a unique leveraging of our in-house expertise to deliver the right competencies where and when you need them. With a well-integrated local presence in the Nordics, UK, and Germany, you can trust us to make your journey to market as simple and cost-effective as possible.

Your Full-service contract research organization (CRO)

A strategic partnership

"The TPP workshop provided by LINK Medical substantially improved our strategy and made the planning of clinical trials much easier"

"The TPP workshop gave us an excellent, clear understanding of the regulatory pathway. Having experts from different areas of the health care sector in the same room, answering all our questions, was a fantastic benefit for us"

The health economic model proved to be an extremely useful tool, enabling Mentis Cura to explore the monetary effect of implementing it's product in multiple scenarios.

Link Medical’s interactive presentation encouraged discussion and experience sharing between companies allowing some of our younger companies to quickly identify potential regulatory issues.

Latest Updates